Well I am just getting caught up on today's posts. I don't have enough free posts to comment on all of the great posts I read today, so let me say thanks to all, for all the great info!
Just a personal thought on when the 4th Qtr results will be released. The 12th of Dec or possibly a few days later. Why then? APDN is audited by an outside agency and doesn't really control when the audit will be completed. I believe that once that date is known, APDN will release a PR of the date and instructions on how to sign up for the webinar where our motivational speaker Dr Hayward will discuss past performance and generic future aspirations. Sorry guys, couldn't resist that motivational part :)
What I saw today was a renewed faith /hope/ belief in APDN and the future potential we all hope exists for APDN. I do believe we will reach that potential!
Again, I think it is important to understand Dr Hayward's background to fully understand what avenues and contacts he has developed over the years that could lead to possible contracts for APDN in the future. He is extremely well connected and well respected as are the other members of the company. Look at what he has accomplished with the APDN since he has taken over, more than all the other accomplishments leading up to his arrival.
We may see some unique and unexpected contracts develop that we have not heard or thought of yet. Unfortunately, we have heard many times that some of these parties want their relationship with APDN to remain silent.
We have heard the words "Pilot Program" several times which means no real revenue for APDN. The marking kits in Britan comes to mind. We need to get our foot in the door and if you look at what happened with Nissha, it has led to expansion of our contracts with them. Also, it may lead to expansion with DLA and the other FSC classes we read about here the other day.
We all know about MDA and what that could mean for the company since they may be looked at as the possible model for all of DoD in terms of anti-counterfeiting as alluded to be some senators.
This is just another posting of Dr Haywards credentials. I think if you take the time to think about what he has achieved and who he knows, you may feel a little bit more comfortable about what he is doing and how he is handling business matters for APDN.
KEEP IN MIND THIS IS ONLY MY OPINION!!! GLTA! AND GREAT EFFORT BY ALL HERE, SO THANKS AGAIN.
Personal request now that we have elevated our position with the active investigation, let's keep this board as clean as we can. Our posts are rise to the top of Google's search when anyone looks at APDN. I totally understand the frustration that we all feel from time to time with the MM's and some posters on here, but we have a very talented group of people on here and many stay here because of the qaulity of this board. Kudos to everyone!
So here is Dr Hayward's cut and paste. Sory fur eny tipos guys, ben a leight day 4 me and i am whiped out!
Dr. Hayward has been the President of Applied DNA Sciences Inc., since June 12, 2007. He has over 15 years of experience in the consumer product, biotech and pharmaceutical industries. He served as General Partner of Double D Venture Fund, a venture capital firm based in New York. He founded Collaborative Laboratories Inc. (CLI) in 1990 and served as its President. Dr. Hayward served as Principal Financial Officer and Principal Accounting Officer of Applied DNA Sciences Inc., since October 17, 2005 and served as its Acting Chief Executive Officer from October 5, 2005 to March 17, 2006. He served as Vice President of Personal Care & Life Sciences for BASF Catalysts LLC (also known as Engelhard Corp.), since August 2004. From 1990 to July 2004, he served as Chairman, President and Chief Executive of Collaborative Group Ltd. In 1983, Dr. Hayward was one of the founding Principals and Research Director of Europe’s first liposome company, Biocompatibles Ltd. He has been a Director of Applied DNA Sciences Inc., since March 17, 2006. From 1984 to 1989, he was responsible for product development at Esteé Lauder Companies, where he served as Director of Research Worldwide. Since June 2004, Dr. Hayward has been the Chairman of Evotope Biosciences Inc. Since 2001, he has been a Director of Q-RNA Inc. He serves on the boards of the Council on Biotechnology and the Research Foundation of the State of New York (Research Foundation Of State University Of New York, The). He serves as a Director of Softheon, Inc. He served as Director of Long Island Life Sciences Initiative (LILSI), Long Island Association Inc., Stony Brook Foundation, and the New York Biotechnology Association Inc. Dr. Hayward has more than 50 patents and original publications to his credit regarding the applications of liposomes. He received his Doctorate in Molecular Biology and Biophysics from SUNY at Stony Brook. Dr. Hayward received his Bachelors degree in Biology and Chemistry from the State University of New York at Oneonta in 1976 and his Ph.D. in Molecular Biology from the State University of New York at Stony Brook in 1983.
AI
